NYXHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Nyxoah SA

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026

$0.95−0.16 (-14.05%)

Close on Oct 19, 2026

Nyxoah SA cash flow statement

Annual Quarterly TTM

EUR USD

Millions of EUR, except per-share data. Shares in millions.

Line item	TTM FY 2022 2022-12-31	TTM FY 2021 2021-12-31
Stock-Based Compensation	2.70	1.27
Change in Inventory	-0.54	-0.29
Operating Cash Flow	-29	-25
Capital Expenditures	-0.89	-1.47
Investing Cash Flow	-90	-12
Stock Issued	0.26	78
Debt Repaid	-0.08	-0.08
Financing Cash Flow	-0.98	76
Foreign Exchange Rate Adjustments	2.06	3.89
Free Cash Flow	-30	-27

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -111.0%

Financial strength

Current ratio: 2.38
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 135.6%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.